Caption Management’s Olema Pharmaceuticals OLMA Stock Holding History

Caption Management’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$225K	Sell	18,000 -17,000	-49%	-$228K	﹤0.01%	1450
2026 Q1	$522K	Buy	+35,000	New	+$779K	﹤0.01%	1199
2025 Q1	–	Sell	-17,600	Closed	-$103K	–	1891
2024 Q4	$103K	Hold	17,600	–	–	﹤0.01%	1334
2024 Q3	$210K	Buy	+17,600	New	+$225K	﹤0.01%	1057
2024 Q1	–	Sell	-2,000	Closed	-$28.1K	–	1552
2023 Q4	$28.1K	Buy	+2,000	New	+$26.9K	﹤0.01%	1248

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Caption Management's OLMA Position: Q2 2026 in Review

Caption Management reduced its Olema Pharmaceuticals (OLMA) stake by 49% in Q2 2026, selling an estimated $228K and leaving 18,000 shares worth $225K. The position accounts for ﹤0.01% of the portfolio, ranked #1450.

Caption Management first reported a position in OLMA in Q4 2023 and has held it in 5 quarters since. The position peaked at $522K in Q1 2026. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

Caption Management held 18,000 shares of Olema Pharmaceuticals worth $225K as of Q2 2026.
Caption Management sold 17,000 Olema Pharmaceuticals shares in Q2 2026, an estimated $228K.
Olema Pharmaceuticals made up ﹤0.01% of Caption Management's portfolio in Q2 2026, its #1450 holding.
Caption Management first reported a position in Olema Pharmaceuticals in Q4 2023 and has held it in 5 quarters since.
Caption Management's Olema Pharmaceuticals position peaked at $522K in Q1 2026.
185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.